GE Loans XDx $12.5M

Xconomy San Francisco — 

XDx, the Brisbane, CA-based molecular diagnostics company, said today that it has secured a $12.5 million loan from GE Capital, Healthcare Financial Services (technically it called the loan a “senior secured multi-draw term loan facility”). The company said the funds will give it enough runway to move forward with commercialization of its FDA-approved “AlloMap” test, which can detect whether a transplanted organ is being rejected. XDx CEO Pierre Cassigneul told Xconomy last month that he expects the company to become profitable in 2011, after raising some $140 million in capital over its 11 years in business.